|
Volumn 11, Issue 8 Suppl 8, 1997, Pages 25-30
|
Docetaxel vs mitomycin plus vinblastine in anthracycline-resistant metastatic breast cancer.
a a a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC ANTIBIOTIC;
DOCETAXEL;
DRUG DERIVATIVE;
MITOMYCIN;
PACLITAXEL;
TAXOID;
VINBLASTINE;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
BREAST TUMOR;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONSTIPATION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE COURSE;
DISEASE FREE SURVIVAL;
DRUG RESISTANCE;
FEMALE;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
METASTASIS;
MIDDLE AGED;
MULTICENTER STUDY;
PHASE 3 CLINICAL TRIAL;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
REMISSION;
SAFETY;
SURVIVAL RATE;
THROMBOCYTOPENIA;
ADOLESCENT;
ADULT;
AGED;
ANTIBIOTICS, ANTINEOPLASTIC;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
CONSTIPATION;
DISEASE PROGRESSION;
DISEASE-FREE SURVIVAL;
DRUG RESISTANCE, NEOPLASM;
FEMALE;
HUMANS;
INFUSIONS, INTRAVENOUS;
MIDDLE AGED;
MITOMYCINS;
NEOPLASM METASTASIS;
PACLITAXEL;
QUALITY OF LIFE;
REMISSION INDUCTION;
SAFETY;
SURVIVAL RATE;
TAXOIDS;
THROMBOCYTOPENIA;
VINBLASTINE;
|
EID: 0031204228
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (16)
|
References (0)
|